Molecular imaging techniques such as PET and SPECT have been used to shed light on
how coronavirus disease 2019 (COVID-19) affects the human brain. We provide a …

Background Nearly 40% of patients who experience smell loss during SARS-CoV-2
infection may develop qualitative olfactory dysfunction, most commonly parosmia. Our …

Objective Olfactory dysfunction (OD) is a common presenting symptom of COVID‐19
infection. Radiological imaging of the olfactory structures in patients with COVID‐19 and OD …

Although parosmia is a common problem in the era of the COVID-19 pandemic, few studies
assessed the demographic and clinical aspects of this debilitating symptom. We aimed to …

An altered sense of smell and taste was recognized as one of the most characteristic
symptoms of coronavirus infection disease (COVID-19). Despite most patients experiencing …

Rationale and Objectives Hyposmia/anosmia is common among patients with coronavirus
disease-2019 (COVID-19). Various imaging modalities have been used to assess olfactory …

The emergence of SARS-CoV-2 has brought olfactory dysfunction to the forefront of public
awareness, because up to half of infected individuals could develop olfactory dysfunction …

Deficiencies in smell and taste are common symptoms of COVID-19. Quantitative losses are
well surveyed. This study focuses on qualitative changes such as phantosmia (hallucination …

Background Recently, anosmia and ageusia (and their variations) have been reported as
frequent symptoms of COVID-19. Olfactory and gustatory stimuli are essential in the …

Abstract Purpose of Review The purpose of this review was to summarize the current
knowledge on parosmia and phantosmia and introduce support and treatment algorithms for …